AVITA Medical, Inc.
RCEL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $18,418 | $18,514 | $18,406 | $19,546 |
| % Growth | -0.5% | 0.6% | -5.8% | – |
| Cost of Goods Sold | $3,469 | $2,833 | $2,280 | $3,190 |
| Gross Profit | $14,949 | $15,681 | $16,126 | $16,356 |
| % Margin | 81.2% | 84.7% | 87.6% | 83.7% |
| R&D Expenses | $5,117 | $6,284 | $4,850 | $5,428 |
| G&A Expenses | $6,666 | $6,390 | $7,124 | $9,590 |
| SG&A Expenses | $20,980 | $21,224 | $21,233 | $24,734 |
| Sales & Mktg Exp. | $14,314 | $14,834 | $14,109 | $15,144 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $26,097 | $27,508 | $26,083 | $30,162 |
| Operating Income | -$11,148 | -$11,827 | -$9,957 | -$13,806 |
| % Margin | -60.5% | -63.9% | -54.1% | -70.6% |
| Other Income/Exp. Net | $1,232 | -$2,024 | -$1,613 | -$2,427 |
| Pre-Tax Income | -$9,916 | -$13,851 | -$11,570 | -$16,233 |
| Tax Expense | $4 | $8 | $19 | -$28 |
| Net Income | -$9,920 | -$13,859 | -$11,589 | -$16,205 |
| % Margin | -53.9% | -74.9% | -63% | -82.9% |
| EPS | -0.38 | -0.53 | -0.44 | -0.62 |
| % Growth | 28.3% | -20.5% | 29% | – |
| EPS Diluted | -0.38 | -0.53 | -0.44 | -0.62 |
| Weighted Avg Shares Out | 26,368 | 26,254 | 26,146 | 25,984 |
| Weighted Avg Shares Out Dil | 26,368 | 26,254 | 26,146 | 25,984 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,252 | $1,233 | $1,298 | $1,359 |
| Depreciation & Amortization | $552 | $521 | $409 | $310 |
| EBITDA | -$8,112 | -$12,097 | -$9,863 | -$14,564 |
| % Margin | -44% | -65.3% | -53.6% | -74.5% |